Thermo Fisher Scientific (TMO) Net Equity Issued and Repurchased (2009 - 2014)

Thermo Fisher Scientific has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $2.9 billion in Q1 2014.

• Net Equity Issued and Repurchased for Q1 2014 came in at $2.9 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $2.9 billion (changed N/A YoY), and the FY2017 annual result was $1.7 billion, changed N/A from the prior year.
• Net Equity Issued and Repurchased rose to $2.9 billion in Q1 2014, from -$131.3 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $2.9 billion in Q1 2014 and troughed at -$131.3 million in Q4 2012.
• A 4-year average of $244.4 million and a median of $24.7 million in 2010 frame the typical range for Net Equity Issued and Repurchased.
• The largest YoY upside for Net Equity Issued and Repurchased was 467.23% in 2012 against a maximum downside of 3084.09% in 2012.
• A 4-year view of Net Equity Issued and Repurchased shows it stood at $24.7 million in 2010, then slumped by 82.19% to $4.4 million in 2011, then sank by 3084.09% to -$131.3 million in 2012, then jumped by 2340.67% to $2.9 billion in 2014.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $2.9 billion in Q1 2014, -$131.3 million in Q4 2012, and $67.5 million in Q3 2012.